Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 24, 2009

Kyoto Buys Fluidigm’s Technology to Research Stem Cell Reprogramming

  • Kyoto University’s Center for iPS Cell Research and Application (CiRA) purchased Fluidigm’s BioMark™ System to use in researching stem cell reprogramming.

    CiRA is using the microfluidic properties of BioMark’s integrated fluidic circuits to analyze selected genes in induced pluripotent stem (iPS) cells. The institute is also using the system to quantify copies of specific genes transferred into a cell to generate iPS cells.



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »